Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) EBT Margin: 2024-2025

Historic EBT Margin for Prime Medicine (PRME) over the last 2 years, with Sep 2025 value amounting to -4,312.82%.

  • Prime Medicine's EBT Margin rose 2081541.00% to -4,312.82% in Q3 2025 from the same period last year, while for Sep 2025 it was -3,339.28%, marking a year-over-year change of. This contributed to the annual value of -6,566.61% for FY2024, which is N/A change from last year.
  • Per Prime Medicine's latest filing, its EBT Margin stood at -4,312.82% for Q3 2025, which was up 8.56% from -4,716.68% recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's EBT Margin peaked at -1,936.60% during Q4 2024, and registered a low of -25,128.23% during Q3 2024.
  • Over the past 2 years, Prime Medicine's median EBT Margin value was -4,514.75% (recorded in 2025), while the average stood at -7,897.23%.
  • Data for Prime Medicine's EBT Margin shows a peak YoY soared of 2,081,541bps (in 2025) over the last 5 years.
  • Over the past 2 years, Prime Medicine's EBT Margin (Quarterly) stood at -1,936.60% in 2024, then surged by 2,081,541bps to -4,312.82% in 2025.
  • Its EBT Margin stands at -4,312.82% for Q3 2025, versus -4,716.68% for Q2 2025 and -3,568.78% for Q1 2025.